A trial tested the efficacy of corticosteroids in reducing interstitial fibrosis after kidney transplantation in low-risk patients.

The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

With investors and drugmakers increasingly eyeing the kidney disease space, a new company hopes to shed its underdog status ...

Exposure-response association seen between trihalomethanes and CKD risk; highest risk seen for brominated trihalomethanes.

Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

The company raised $54.5 million to make treatments that restore protein function in polycystic kidney disease ...

Long-term exposure to water contaminants, even below the regulatory limits, significantly increases the risk of chronic ...

Landlords say no Company wants out of big biotech leases. Landlords say no How this Peninsula biotech plans to survive after ...

Researchers conducted a post hoc analysis of the SURMOUNT-1 trial to assess the effect of tirzepatide on kidney function in prediabetes with obesity or overweight.